Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics società ha sostenuto
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più
Long hours. Stressful, not having training was hard to learn when things are constantly changing.
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
People are pleasant for the most part.
Quali sono alcune delle cose migliori della tuo team?
Ability to communicate with all departments maintaining timelines
Che cosa deve fare il gruppo dirigente per migliorare?
Listening, not making rash/ fast decisions. Give employees time to breath,
Perché ti senti sottovalutato e che cosa ti farebbe sentire meglio con il tuo compenso?
no autonomy- creating the need to have multiple meeting- -my input and my time
Other Employee Reviews for Karyopharm Therapeutics
×